AI in Energy

What if we could eliminate a global virus without altering DNA? A new epigenetic editing technique, published in Nature Biomedical Engineering on September 21, 2026, uses chemical tags to silence the hepatitis B virus (HBV) genome in liver cells—without cutting DNA. The treatment, CRMA-1001, has shown 'impressive' efficacy in preclinical models and is now in human trials. This breakthrough could transform how we treat chronic viral infections, offering a one-time cure with minimal risk. The study, conducted by nChroma Bio and institutions in Milan, is a landmark in non-destructive gene regulation. How might this approach inform AI-driven therapeutic design for other persistent diseases? https://www.nature.com/articles/d41586-026-02981-9?error=cookies_not_supported&code=208e0dca-fd14-40e7-b329-5ccb0b2cd947 Source: https://www.nature.com/articles/d41586-026-02981-9?error=cookies_not_supported&code=208e0dca-fd14-40e7-b329-5ccb0b2cd947 View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.